Presentation of the 2021 BioRegion Report
26.01.2022
26.01.2022
<p>AXA Auditorium, Barcelona and <em>online</em></p>
<p>AMGEN, AliraHealth, EATRIS+, EY and Pons IP</p>
Biocat, CataloniaBio & HealthTech and ACCIÓ
The presentation of the 2021 BioRegion of Catalonia Report, the benchmark study that analyzes the life sciences and healthcare sector in Catalonia, will take place on January 26 in hybrid format *: in person at the AXA Auditorium in Barcelona and will also be streamed. The report is promoted by Biocat, together with CataloniaBio & HealthTech and ACCIÓ.
In addition to the presentation of the main indicators and results from the report, we’ll also have two panel discussions to share experiences from benchmark countries in regulatory issues and speak about the BioRegion’s commitment to becoming a hub for advanced therapies and precision medicine.
How have the main health innovation indicators evolved this year of the pandemic? Has more been invested than last year? How is Catalonia positioned on the stock markets? What should be taken into account in putting together an international market access strategy? Save your spot and find it out.
Check 2021 BioRegion Report
Program
10:00 am – Institutional Welcome
- Robert Fabregat, CEO, Biocat
10:05 am - Presentation of the 2021 BioRegion Report
- Robert Fabregat, CEO, Biocat
- Natàlia Mas, Director General of Industry, Government of Catalonia and CEO, Catalonia Trade & Investment
- Jaume Amat, President, CataloniaBio & HealthTech
In collaboration with Silvia Ondategui, Partner Life Sciences, Ernst & Young
11h – Networking (outdoors)
11:45 am – Round table: “Hi, I’m an SME, where is my fast track?”
Chair: Montserrat Daban, Scientific and International Relations Director of Biocat
- Healthcare marketplace: a go-to market strategy across Europe – Richard Charter, Vice President, Market Access MedTech Europa and Asia-Pacific at Alira Health
- The DiGA Fast Track, enabling digital transformation – Marco Wendel, CEO at Medical Valley Digital Health Application Center GmbH
- Transposing the DiGA to the French market – Nina Bufi, eHealth Projects Director at French Ministry of Health
- Evidence, evidence and evidence - support for market access and adoption in the UK – Suzanne Ali-Hassan, Deputy Director, Commercial & Innovation at UCL Partners
- The five keywords of value-based procurement – Ramon Maspons, CIO at Agency for Health Quality and Assessment of Catalonia (AQuAS)
12:45 am – The Next Generation bet for the BioRegion: a hub of excellence in emerging therapies and personalized medicine
Chair: Robert Fabregat, CEO, Biocat
- Mariona Sanz, Managing Director of European Funds, Government of Catalonia
- Fina Lladós, General Manager Iberia, AMGEN
- Toni Andreu, Scientific Director, EATRIS
- Joan Comella, Secretary, ACER (Catalan Association of Research Entities)
- Ignasi Biosca, CataloniaBio & HealthTech and Managing Director, Reig Jofre
13:30h. – Cloenda
- The Hon. Pere Aragonès, President of the Government of Catalonia
13:40h. – Networking (outdoors)
More information
* IMPORTANT NOTE: This event is scheduled to be held at the AXA Auditorium (Barcelona) if the situation and the Covid measures in place at that date allow it. Following the current protocol and security measures, you will be asked for the Covid passport (digitally or on paper) or a negative PCR / antigen test to access the event, as well as your ID or identification document. We recommend that you arrive early to avoid crowds.
In collaboration with:
With the support of:
